February 2010 in “Journal of The American Academy of Dermatology” NB-002 is a promising new topical treatment for fungal nail infections, showing better results than a non-medicated option.
2 citations
,
October 2021 in “Journal of skin and stem cell” This study observed that nail abnormalities often indicate underlying dermatological or systemic conditions, with psoriasis and infections being the most common causes among patients.
February 2010 in “Journal of The American Academy of Dermatology” This study found that the novel antifungal emulsion NB-002 demonstrated significant antifungal activity and nail clearing in patients with distal subungual onychomycosis involving ≤50% of the nail.
February 2010 in “Journal of The American Academy of Dermatology” This study found that NB-002 demonstrated clear antifungal activity and clinically significant nail clearing in subjects with distal subungual onychomycosis and ≤50% nail involvement, compared to a vehicle treatment.
February 2010 in “Journal of The American Academy of Dermatology” This study found that NB-002, a novel topical antifungal, showed significant antifungal activity and clinically meaningful nail clearing in patients with mild to moderate distal subungual onychomycosis.